Search Results
BOLERO-1 reports HER2-positive breast cancer latest PFS data
Comment: BOLERO-1 reports HER2-positive breast cancer latest PFS data
Progression-free survival results from BOLERO-1 trial
Dr. Baselga Discusses the BOLERO Breast Cancer Trials
SABCS2014: Progression-free Survival Results From BOLERO-1 Trial
Novel Therapeutics for Breast Cancer: HER2+ and Triple Negative Disease; New Pathways, Targets
Frontline T-DM1 in HER2-Positive Metastatic Breast Cancer
Dr. Yardley Discusses the Role of Everolimus in Breast Cancer and the BOLERO Trials
High tumour immune cell levels may help screen HER2-positive breast cancer patients for chemo
Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast Cancer
Stefan Gluck, MD: Avastin Improves PFS in HER2-Positive Breast Cancer in AVEREL Study
Advanced Breast Cancer: Challenges in Pathways Development